-
1
-
-
34247383888
-
Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis
-
Thamer M., Zhang Y., Kaufman J., Cotter D., Dong F., and Hernan M.A. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. JAMA 297 (2007) 1667-1674
-
(2007)
JAMA
, vol.297
, pp. 1667-1674
-
-
Thamer, M.1
Zhang, Y.2
Kaufman, J.3
Cotter, D.4
Dong, F.5
Hernan, M.A.6
-
2
-
-
33751002326
-
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
-
Drueke T.B., Locatelli F., Clyne N., et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355 (2006) 2071-2084
-
(2006)
N Engl J Med
, vol.355
, pp. 2071-2084
-
-
Drueke, T.B.1
Locatelli, F.2
Clyne, N.3
-
3
-
-
33750983605
-
Correction of anemia with epoetin alfa in chronic kidney disease
-
Singh A.K., Szczech L., Tang K.L., et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 (2006) 2085-2098
-
(2006)
N Engl J Med
, vol.355
, pp. 2085-2098
-
-
Singh, A.K.1
Szczech, L.2
Tang, K.L.3
-
5
-
-
34247333302
-
Use of epoetin in chronic renal failure
-
Coyne D.W. Use of epoetin in chronic renal failure. JAMA 297 (2007) 1713-1716
-
(2007)
JAMA
, vol.297
, pp. 1713-1716
-
-
Coyne, D.W.1
-
6
-
-
0030363844
-
The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients
-
Beusterien K.M., Nissenson A.R., Port F.K., Kelly M., Steinwald B., and Ware Jr. J.E. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 7 (1996) 763-773
-
(1996)
J Am Soc Nephrol
, vol.7
, pp. 763-773
-
-
Beusterien, K.M.1
Nissenson, A.R.2
Port, F.K.3
Kelly, M.4
Steinwald, B.5
Ware Jr., J.E.6
-
7
-
-
0025190665
-
The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group
-
Evans R.W., Rader B., and Manninen D.L. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA 263 (1990) 825-830
-
(1990)
JAMA
, vol.263
, pp. 825-830
-
-
Evans, R.W.1
Rader, B.2
Manninen, D.L.3
-
8
-
-
0028945387
-
Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients
-
Revicki D.A., Brown R.E., Feeny D.H., et al. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 25 (1995) 548-554
-
(1995)
Am J Kidney Dis
, vol.25
, pp. 548-554
-
-
Revicki, D.A.1
Brown, R.E.2
Feeny, D.H.3
-
9
-
-
0034765367
-
Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%
-
Collins A.J., Li S., St Peter W., et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol 12 (2001) 2465-2473
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 2465-2473
-
-
Collins, A.J.1
Li, S.2
St Peter, W.3
-
10
-
-
0033052842
-
Hematocrit level and associated mortality in hemodialysis patients
-
Ma J.Z., Ebben J., Xia H., and Collins A.J. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10 (1990) 610-619
-
(1990)
J Am Soc Nephrol
, vol.10
, pp. 610-619
-
-
Ma, J.Z.1
Ebben, J.2
Xia, H.3
Collins, A.J.4
-
11
-
-
0029284007
-
Implementing the Health Care Quality Improvement Program in the Medicare ESRD Program: a new era of quality improvement in ESRD
-
McClellan W.M., Helgerson S.D., Frederick P.R., Wish J.B., and McMullan M. Implementing the Health Care Quality Improvement Program in the Medicare ESRD Program: a new era of quality improvement in ESRD. Adv Ren Replace Ther 2 (1995) 89-94
-
(1995)
Adv Ren Replace Ther
, vol.2
, pp. 89-94
-
-
McClellan, W.M.1
Helgerson, S.D.2
Frederick, P.R.3
Wish, J.B.4
McMullan, M.5
-
12
-
-
33750143686
-
Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis
-
Rocco M.V., Frankenfield D.L., Hopson S.D., and McClellan W.M. Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med 145 (2006) 512-519
-
(2006)
Ann Intern Med
, vol.145
, pp. 512-519
-
-
Rocco, M.V.1
Frankenfield, D.L.2
Hopson, S.D.3
McClellan, W.M.4
-
13
-
-
33847309142
-
In the literature: on clinical performance measures and outcomes among hemodialysis patients
-
Parfrey P.S. In the literature: on clinical performance measures and outcomes among hemodialysis patients. Am J Kidney Dis 49 (2007) 352-355
-
(2007)
Am J Kidney Dis
, vol.49
, pp. 352-355
-
-
Parfrey, P.S.1
-
14
-
-
33846032712
-
Medicare and erythropoietin
-
Steinbrook R. Medicare and erythropoietin. N Engl J Med 356 (2007) 4-6
-
(2007)
N Engl J Med
, vol.356
, pp. 4-6
-
-
Steinbrook, R.1
-
15
-
-
0003775081
-
-
Committee for the Study of the Medicare End-Stage Renal Disease Program, Division of Health Care Services, Washington, DC
-
Rettig R.A., and Levinsky N.G. Committee for the Study of the Medicare End-Stage Renal Disease Program: Kidney Failure and the Federal Government (1991), Committee for the Study of the Medicare End-Stage Renal Disease Program, Division of Health Care Services, Washington, DC
-
(1991)
Committee for the Study of the Medicare End-Stage Renal Disease Program: Kidney Failure and the Federal Government
-
-
Rettig, R.A.1
Levinsky, N.G.2
-
16
-
-
2342422998
-
The direction of end-stage renal disease reimbursement in the United States
-
Lockridge Jr. R.S. The direction of end-stage renal disease reimbursement in the United States. Semin Dial 17 (2004) 125-130
-
(2004)
Semin Dial
, vol.17
, pp. 125-130
-
-
Lockridge Jr., R.S.1
-
17
-
-
0025883657
-
Recombinant erythropoietin and Medicare payment
-
Sisk J.E., Gianfrancesco F.D., and Coster J.M. Recombinant erythropoietin and Medicare payment. JAMA 266 (1991) 247-252
-
(1991)
JAMA
, vol.266
, pp. 247-252
-
-
Sisk, J.E.1
Gianfrancesco, F.D.2
Coster, J.M.3
-
18
-
-
17044458483
-
The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients
-
de Lissovoy G., Powe N.R., Griffiths R.I., et al. The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients. Med Care 32 (1994) 130-140
-
(1994)
Med Care
, vol.32
, pp. 130-140
-
-
de Lissovoy, G.1
Powe, N.R.2
Griffiths, R.I.3
-
19
-
-
34548049945
-
-
United States Department of Health and Human Services Office of the Inspector GeneralMedicare reimbursement for Existing End-Stage Renal Disease Drugs. Available at: http://www.medicarerxguide.com/MDRG/2005/oei-03-04-00120.pdf. Accessed July 17, 2007
-
-
-
-
20
-
-
0030921662
-
NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
-
National Kidney Foundation
-
National Kidney Foundation. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 30 suppl 3 (1997) S192-S240
-
(1997)
Am J Kidney Dis
, vol.30
, Issue.SUPPL. 3
-
-
-
21
-
-
0035228407
-
K/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000
-
National Kidney Foundation
-
National Kidney Foundation. K/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000. Am J Kidney Dis 37 suppl 1 (2001) S182-S238
-
(2001)
Am J Kidney Dis
, vol.37
, Issue.SUPPL. 1
-
-
-
22
-
-
34547414592
-
Hemoglobin Level Variability: Associations with Comorbidity, Intercurrent Events, and Hospitalizations
-
Ebben J.P., Gilbertson D.T., Foley R.N., and Collins A.J. Hemoglobin Level Variability: Associations with Comorbidity, Intercurrent Events, and Hospitalizations. Clin J Am Soc Nephrol 1 (2006) 1205-1210
-
(2006)
Clin J Am Soc Nephrol
, vol.1
, pp. 1205-1210
-
-
Ebben, J.P.1
Gilbertson, D.T.2
Foley, R.N.3
Collins, A.J.4
-
23
-
-
32644457068
-
Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin
-
Fishbane S., and Berns J.S. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 68 (2005) 1337-1343
-
(2005)
Kidney Int
, vol.68
, pp. 1337-1343
-
-
Fishbane, S.1
Berns, J.S.2
-
24
-
-
33646339958
-
KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults
-
National Kidney Foundation
-
National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis 47 suppl 3 (2006) S16-S85
-
(2006)
Am J Kidney Dis
, vol.47
, Issue.SUPPL. 3
-
-
-
25
-
-
34548046760
-
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target
-
National Kidney Foundation
-
National Kidney Foundation. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target. Am J Kidney Dis 50 (2007) 471-530
-
(2007)
Am J Kidney Dis
, vol.50
, pp. 471-530
-
-
-
26
-
-
33845487545
-
EPO adjustments in patients with elevated hemoglobin levels: provider practice patterns compared with recommended practice guidelines
-
Collins A.J., Ebben J.P., and Gilbertson D.T. EPO adjustments in patients with elevated hemoglobin levels: provider practice patterns compared with recommended practice guidelines. Am J Kidney Dis 49 (2007) 135-142
-
(2007)
Am J Kidney Dis
, vol.49
, pp. 135-142
-
-
Collins, A.J.1
Ebben, J.P.2
Gilbertson, D.T.3
|